This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Harvard College, The General Hospital Corporation. Active years: 1997.
Company Filing History:
1 out of 3,071 
1 out of 3,070 
Years Active: 1997
Title: The Innovations of Ben Z Stanger
Introduction
Ben Z Stanger is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of biomedical research, particularly in understanding cell death mechanisms. His work has implications for various medical applications, including cancer research.
Latest Patents
Stanger holds a patent for a protein designated as RIP. This protein contains a death domain at its carboxy terminus and a kinase domain at its amino terminus. RIP interacts with the Fas/APO-1 intracellular domain and the TNFR1 intracellular domain. When expressed in transformed host cells, recombinant RIP promotes apoptosis. Additionally, his patent includes DNA molecules encoding RIP, anti-RIP antibodies, and screening methods for discovering inhibitors of RIP-dependent apoptosis. He has 1 patent to his name.
Career Highlights
Throughout his career, Stanger has worked with prestigious institutions such as Harvard College and The General Hospital Corporation. His research has contributed to a deeper understanding of apoptosis and its role in various diseases.
Collaborations
Some of his notable coworkers include Philip Leder and Brian Seed. Their collaborative efforts have further advanced the research in the field of cell biology.
Conclusion
Ben Z Stanger's innovative work in the realm of cell death proteins has paved the way for future research and potential therapeutic applications. His contributions continue to influence the scientific community and enhance our understanding of critical biological processes.